Home World News Treatment with Obecabtagene Autoleucel Results in Durable Response Among Adults with Relapsed... World News Treatment with Obecabtagene Autoleucel Results in Durable Response Among Adults with Relapsed or Refractory B-Cell ALL By Ogkologos - December 12, 2024 939 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the FELIX study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR ASCO 2021 news: follow-up treatments pave the way June 9, 2021 EMA Recommends Extension of Indications for Nivolumab October 20, 2020 Abnormal Results from Prenatal Blood Test Could Point to Cancer in... February 21, 2025 When Ellen Found Out There Was A Grieving Mother In The... March 12, 2019 Load more HOT NEWS Expecting Mom Finds Pregnant Stray Cat And Gives Her A Home How My Navy Career Helped Shape My Positive Attitude During My... Spending Review 2020 – Steps in the right direction, but opportunities... EMA Recommends Granting a Marketing Authorisation for Phesgo (Pertuzumab / Trastuzumab)
